The Branded Generics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Branded Generics Market:
https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report
According to The Business Research Company’s Branded Generics Global Market Report 2024, The branded generics market size has grown strongly in recent years. It will grow from $335.98 billion in 2023 to $367.67 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to cost savings and affordability, patent expiries, market expansion and access, government initiatives and policies, healthcare reforms.
The branded generics market size is expected to see rapid growth in the next few years. It will grow to $542.32 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing demand for generic biologics, rising chronic diseases, emerging markets growth, focus on biosimilars. Major trends in the forecast period include strategic partnerships and collaborations, technological advancements, focus on chronic diseases, market consolidation, patient-centric approach.
The increasing prevalence of chronic diseases will drive the growth rate of branded generics market. Chronic diseases are long-lasting sicknesses that often cannot be healed; however, they are curable and controllable. Chronic diseases are increasing due to the increasing use of tobacco products, poor nutrition, physical inactivity, excessive use of alcohol, and others. Customers across the globe are more inclined toward branded generics to treat chronic diseases as they purchase them at a lower cost than usual medications. For instance, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, there were 41 million deaths, which is 74% of all deaths caused by noncommunicable diseases (NCDs) or chronic diseases every year globally. Thus, an increase in the prevalence of chronic diseases is expected to boost the demand for branded generics during the forecast period.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=7186&type=smp
The branded generics market covered in this report is segmented –
1) By Drug Class: Alkylating Agents, Antimetabolites, Hormones, Anti-hypertensive, Lipid Lowering Drugs, Anti-depressants, Anti-psychotics, Anti-Epileptics, Other Drugs
2) By Route of Administration: Topical, Oral, Parenteral, Other Routes of Administration
3) By Application: Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-inflammatory, Other Applications
In June 2022, Dr. Reddy’s Laboratories, an India-based pharmaceutical company that provides branded generics, acquired branded and generic injectable products from Eton Pharmaceuticals, Inc. for $50 million. With this acquisition, Dr. Reddy’s Laboratories aims to accelerate and expand affordable medications for patients with branded generics such as Biorphen (phenylephrine hydrochloride) injection and Rezipres and launch biosimilars. Eton Pharmaceuticals, Inc., a US-based pharmaceutical company.
The branded generics market report table of contents includes:
- Executive Summary
- Branded Generics Market Characteristics
- Branded Generics Market Trends And Strategies
- Branded Generics Market – Macro Economic Scenario
- Global Branded Generics Market Size and Growth
.
.
.
- Global Branded Generics Market Competitive Benchmarking
- Global Branded Generics Market Competitive Dashboard
- Key Mergers And Acquisitions In Branded Generics Market
- Branded Generics Market Future Outlook and Potential Analysis
- Appendix
Top Major Players
- Pfizer Inc.
- Hoffmann-La Roche A
- Sanofi SA
- AstraZeneca PL
- GlaxoSmithKline PLC,
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
